KR840000525A - 1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산의 제조방법 - Google Patents

1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산의 제조방법 Download PDF

Info

Publication number
KR840000525A
KR840000525A KR1019820003203A KR820003203A KR840000525A KR 840000525 A KR840000525 A KR 840000525A KR 1019820003203 A KR1019820003203 A KR 1019820003203A KR 820003203 A KR820003203 A KR 820003203A KR 840000525 A KR840000525 A KR 840000525A
Authority
KR
South Korea
Prior art keywords
formula
quinoline
compound
cyclopropyl
dihydro
Prior art date
Application number
KR1019820003203A
Other languages
English (en)
Other versions
KR870000895B1 (ko
Inventor
그로(에 외 1) 클라우스
Original Assignee
에리하 데브리츠, 요아힘 그렘
바이엘 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6145081&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR840000525(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 에리하 데브리츠, 요아힘 그렘, 바이엘 아크티엔 게젤샤프트 filed Critical 에리하 데브리츠, 요아힘 그렘
Publication of KR840000525A publication Critical patent/KR840000525A/ko
Application granted granted Critical
Publication of KR870000895B1 publication Critical patent/KR870000895B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. (a) 하기 일반식 (Ⅱ)의 7-클로로-1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-퀴놀린-3-카복실산을 하기 일반식(Ⅲ)의 피페라진 또는 피페라진 유도체와 반응시키거나, 또는
    (b) R'이 알킬그룹인 상기 (a)의 일반식 (Ⅱ)의 화합물을 하기 일반식 (Ⅲ)의 화합물과 반응시켜 7-피페라지노-퀴놀린-3-카복실산 에스테르를 얻은 다음, 알칼리 조건 하에서 가수분해시켜 일반식 (Ⅰ)의 화합물을 얻은 후, 필요한 경우, 상기 (a) 또는 (b)에서 수득된 일반식 (Ⅰ)의 화합물을 그 염 또는 하이드레이트로 전환시킴을 포함하여 하기 일반식 (Ⅰ)의 1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산 또는 그 염 또는 그 하이드레이트를 제조하는 방법.
  2. 제 1 항 (a)에 있어서, 반응이 희석제 존재하에 수행됨이 특징인 방법.
  3. 제 1 항 (a) 또는 제 2 항에 있어서, 반응이 20°내지 200℃ 사이의 온도에서 수행됨이 특징인 방법.
  4. 제 1 항 (b)에 있어서, 반응이 산 결합제 존재하에 수행됨이 특징인 방법.
  5. 대체로 실시예 1 내지 4의 어느 하나에 서술된 바와 같이 일반식 (Ⅰ)의 화합물 또는 그 염이나 하이드레이트를 제조하는 방법.
  6. 유효성분으로서 제 1 항 내지 제 5 항 중 어느 하나의 일반식 (Ⅰ)의 화합물 또는 그 염이나 하이드레이트를 고체 또는 액화 기체 희석제와 혼합시키거나, 계면활성제가 존재할 때를 제외하고는 분자량 200이하의 용매가 아닌 액체 희석제와 혼합하여 포함하는 약제학적 조성물.
  7. 유효성분으로서 제 1 항 내지 제 5 항 중 어느 하나의 일반식 (Ⅰ)의 화합물 또는 그 염이나 하이드레이트를 무균 또는 생리적 등장 수용액 형태로 포함하는 약제학적 조성물.
    상기식에서 R은 수소, 메틸, 에틸 또는 β-하이드록시에틸이며, R1은 수소원자이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8203203A 1981-10-29 1982-07-19 1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산의 제조방법 KR870000895B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19813142854 DE3142854A1 (de) 1981-10-29 1981-10-29 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3142854 1981-10-29
DEP3142854.1 1981-11-29

Publications (2)

Publication Number Publication Date
KR840000525A true KR840000525A (ko) 1984-02-25
KR870000895B1 KR870000895B1 (ko) 1987-05-02

Family

ID=6145081

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8203203A KR870000895B1 (ko) 1981-10-29 1982-07-19 1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산의 제조방법

Country Status (20)

Country Link
EP (1) EP0078362B1 (ko)
JP (5) JPS5874667A (ko)
KR (1) KR870000895B1 (ko)
AT (1) ATE23040T1 (ko)
AU (3) AU561103B2 (ko)
CA (1) CA1218067A (ko)
DD (1) DD202560A5 (ko)
DE (2) DE3142854A1 (ko)
DK (2) DK160491C (ko)
ES (1) ES516921A0 (ko)
FI (1) FI78689C (ko)
GR (1) GR77707B (ko)
HU (1) HU187580B (ko)
IE (1) IE53709B1 (ko)
IL (1) IL66243A (ko)
LU (1) LU88325I2 (ko)
NO (2) NO158018C (ko)
NZ (1) NZ202278A (ko)
PH (1) PH18803A (ko)
ZA (1) ZA824829B (ko)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248505A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(4- (oxoalkyl)-1-piperazinyl/-3-chinolincarbonsaeuren und ihre derivate, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
DE3574380D1 (en) * 1984-02-17 1989-12-28 Daiichi Seiyaku Co 1,8-naphthyridine derivatives
US4542133A (en) * 1984-04-26 1985-09-17 Abbott Laboratories Methylenedioxy quino-benoxazine derivatives and antibacterial use
US4528285A (en) * 1984-04-26 1985-07-09 Abbott Laboratories Methylenedioxy quino-benzothiazine derivatives
US4607032A (en) * 1984-04-26 1986-08-19 Abbott Laboratories Quino-benoxazine antibacterial compounds
US4533663A (en) * 1984-04-26 1985-08-06 Abbott Laboratories Quino-benzothiazine antibacterial compounds
US4529725A (en) * 1984-04-26 1985-07-16 Abbott Laboratories 1-Pyridine substituted quino-benzothiazine
US4540694A (en) * 1984-04-26 1985-09-10 Abbott Laboratories 1-Pyridine substituted quino-benoxazines and antibacterial use
GB8412094D0 (en) * 1984-05-11 1984-06-20 Scras Quinoline derivatives
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3426482A1 (de) * 1984-07-18 1986-01-30 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von halogenierten aroylessigestern
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
DE3502935A1 (de) * 1984-09-29 1986-04-10 Bayer Ag, 5090 Leverkusen 3-amino-2-benzoyl-acrylsaeurederivate und ein verfahren zu ihrer herstellung
FR2574404B1 (fr) * 1984-12-12 1987-04-24 Provesan Sa Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments
DE3576335D1 (de) * 1984-12-14 1990-04-12 Daiichi Seiyaku Co Chinolincarbonsaeure-derivate.
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
JPS61180771A (ja) * 1985-01-05 1986-08-13 バイエル・アクチエンゲゼルシヤフト 安定な抗バクテリア剤水溶液
DE3508816A1 (de) * 1985-01-10 1986-07-10 Bayer Ag, 5090 Leverkusen 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren
DE3501247A1 (de) * 1985-01-16 1986-07-17 Bayer Ag, 5090 Leverkusen Aminoacrylsaeure-derivate
AT392791B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
US4851535A (en) * 1985-01-23 1989-07-25 Toyama Chemical Co., Ltd. Nicotinic acid derivatives
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
EP0224121A3 (en) * 1985-11-19 1987-11-11 ROTTAPHARM S.p.A. 7-[4-amino-piperazinyl]- or 7-[4-chloro-piperazinyl]quinolinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
US4687770A (en) * 1985-12-23 1987-08-18 Abbott Laboratories Isoxazolo-pyrido-benzoxazine and isothiazolo-pyrido-benzoxazine derivatives
US4689325A (en) * 1985-12-23 1987-08-25 Abbott Laboratories Isoxazolo-pyrido-phenoxazine and isothiazolo-pyrido-phenoxazine derivatives
US4772706A (en) * 1986-01-13 1988-09-20 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
JPS62246541A (ja) * 1986-01-20 1987-10-27 Kyorin Pharmaceut Co Ltd ベンゾイル酢酸エステル誘導体とその製造方法
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
DE3641312A1 (de) * 1986-12-03 1988-06-09 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
HU198709B (en) * 1987-04-08 1989-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JP2556330B2 (ja) * 1987-07-09 1996-11-20 杏林製薬株式会社 アニソ−ル誘導体並びにその製造方法
DE3724466A1 (de) * 1987-07-24 1989-02-02 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeuren
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
EP0342849A3 (en) * 1988-05-19 1990-03-14 Pfizer Inc. Intermediates for preparing 1,4-dihydro-4-oxo-quinoline-3-carboxylic acid esters
KR910003630B1 (ko) * 1988-06-17 1991-06-07 한국과학기술원 벤조일 아세틱 에스테르 유도체 및 그 제조방법
GR1000201B (el) * 1988-06-23 1992-03-20 Tsetis Kleon Mέ?οδος για την παρασκευή του 1-κυκλοπροπυλο-6-φ?ορο-1,4-διϋδρο-4-οξο-7κινολίνο-3-καρβοξυλικού οξέος δομικού λί?ου παρασκευής των 1-κυκλοπρόπυλο-6-φ?όρο-1,4-διϋδρο-4οξο-7-πιπεράζινο-κινολινο 3καρβοξυλικών οξέων.
FI95130C (fi) * 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5219781A (en) * 1988-12-08 1993-06-15 Mitsubishi Denki Kabushiki Kaisha Method for manufacturing semiconductor memory device having a stacked type capacitor
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
ES2039301B1 (es) * 1991-11-20 1994-05-16 Genesis Para La Investigacion Procedimiento de obtencion de nuevos intermedios de sintesis utiles para la preparacion de fluoroquinolonas.
ES2050594B1 (es) * 1991-12-31 1994-12-16 Ind Quimica Agropecuaria S A Procedimiento para la obtencion de acidos 6-fluoro-1,4-dihidro-4-oxo-7-piperazino-quinolin-3-carboxilicos sustituidos en 1-n.
ES2050613B1 (es) * 1992-10-16 1996-03-16 Iteve S A Nuevo procedimiento para la preparacion de derivados del acido 1-ciclopropil-3-quinolincarboxilico.
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
ES2088742B1 (es) 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
WO1996037191A1 (en) * 1995-05-24 1996-11-28 Alcon Laboratories, Inc. Antibacterial compositions
DE19547635A1 (de) 1995-12-20 1997-06-26 Bayer Ag Verfahren zur Herstellung von Cyclopropancarbonsäureamiden
JP2003527308A (ja) 1998-12-04 2003-09-16 インフラックス，インコーポレイテッド 多剤輸送体の阻害剤
EP1219618A4 (en) 1999-09-02 2002-09-18 Wakunaga Pharma Co Ltd QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
SE9904108D0 (sv) 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
ATE319710T1 (de) 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102007004732A1 (de) * 2007-01-31 2008-08-07 Bayer Healthcare Ag Enrofloxacin-Hexahydrat
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
WO2013157018A1 (en) 2012-04-18 2013-10-24 Indian Institute Of Technology Madras A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics
CN113912539B (zh) * 2021-12-13 2022-03-11 山东国邦药业有限公司 一种环丙羧酸的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5188973A (ja) * 1975-01-29 1976-08-04 Shinkinakinoronkarubonsanjudotainoseiho
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
JPS5466686A (en) * 1977-09-20 1979-05-29 Dainippon Pharmaceut Co Ltd Quinoline-3-carboxylic acid derivative, its preparation, and pharmaceutical composition containig the same
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS5762259A (en) * 1980-09-05 1982-04-15 Kyorin Pharmaceut Co Ltd Preparation of substituted quinolinecarboxylic acid derivative
IE52125B1 (en) * 1980-10-02 1987-06-24 Fox Charles L Jun 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy
US4788320A (en) * 1986-01-20 1988-11-29 Kyorin Pharmaceutical Co., Ltd. Benzoylacetic acid ester derivatives and process for their preparations
US4689423A (en) * 1986-04-01 1987-08-25 Warner-Lambert Company Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates
JPS6356224A (ja) * 1986-08-27 1988-03-10 株式会社クボタ マルチ作業機の覆土装置
CA2017090A1 (en) * 1990-05-17 1991-11-17 Stephen Dunn Coating composition

Also Published As

Publication number Publication date
NO158018C (no) 1988-06-29
DD202560A5 (de) 1983-09-21
EP0078362A3 (en) 1984-08-22
JPH0463067B2 (ko) 1992-10-08
DK160491C (da) 1991-08-26
FI822442L (fi) 1983-04-30
DE3142854A1 (de) 1983-05-11
NO158018B (no) 1988-03-21
IE821606L (en) 1983-04-29
JPS6362510B2 (ko) 1988-12-02
LU88325I2 (fr) 1994-05-04
KR870000895B1 (ko) 1987-05-02
FI822442A0 (fi) 1982-07-08
CA1218067A (en) 1987-02-17
JPS5874667A (ja) 1983-05-06
NZ202278A (en) 1985-02-28
JPS6322075A (ja) 1988-01-29
FI78689C (fi) 1989-09-11
ES8307787A1 (es) 1983-07-16
DK162637C (da) 1992-04-13
EP0078362A2 (de) 1983-05-11
IL66243A (en) 1987-10-20
AU573125B2 (en) 1988-05-26
AU573126B2 (en) 1988-05-26
JPH04253963A (ja) 1992-09-09
JPS6322076A (ja) 1988-01-29
DK306082A (da) 1983-04-30
GR77707B (ko) 1984-09-25
NO1994030I1 (no) 1994-12-30
AU7140687A (en) 1987-07-30
ES516921A0 (es) 1983-07-16
EP0078362B1 (de) 1986-10-22
FI78689B (fi) 1989-05-31
AU7140587A (en) 1987-08-06
ZA824829B (en) 1983-05-25
PH18803A (en) 1985-09-27
DK162637B (da) 1991-11-25
JPS6322057A (ja) 1988-01-29
NO822346L (no) 1983-05-02
DK190890D0 (da) 1990-08-10
IE53709B1 (en) 1989-01-18
ATE23040T1 (de) 1986-11-15
AU8576882A (en) 1983-05-05
DK160491B (da) 1991-03-18
AU561103B2 (en) 1987-04-30
HU187580B (en) 1986-01-28
JPH0457674B2 (ko) 1992-09-14
IL66243A0 (en) 1982-11-30
JPH0244827B2 (ko) 1990-10-05
DK190890A (da) 1990-08-10
JPH0824536B2 (ja) 1996-03-13
DE3273892D1 (en) 1986-11-27

Similar Documents

Publication Publication Date Title
KR840000525A (ko) 1-사이클로프로필-6-플루오로-1,4-디하이드로-4-옥소-7-피페라지노-퀴놀린-3-카복실산의 제조방법
KR870010005A (ko) 퀴놀린 유도체 및 그의 에스테르 또는 염의 제조법
KR860004025A (ko) 퀴놀론 카복실산의 제조방법
KR840004102A (ko) 퀴놀린 화합물의 제조방법
KR970004204B1 (ko) 퀴놀린 카복실산 붕산 무수물 및 그 제조 방법
KR860007244A (ko) 퀴놀린 카복실산 유도체의 제조방법
KR860003239A (ko) 퀴놀론 카복실산 유도체의 제조방법
KR890701564A (ko) 퀴놀린 카복실산 유도체를 제조하는 방법
KR870003095A (ko) 퀴놀론 카복실산 유도체의 제조방법
HRP930558A2 (en) Process for the preparation of norfloxacine intermediates
KR930019635A (ko) 3-히드록시메틸-1-프로파르길이미다졸리딘-2,4-디온의 제조방법
KR870004974A (ko) 퀴놀론 카복실산 유도체의 제조방법
KR0140158B1 (ko) 퀴놀론카르복실산 유도체의 제조방법
KR940000453A (ko) 퀴놀론 유도체의 신규한 제조방법
KR880012613A (ko) 퀴놀린카르복실산 유도체 및 그를 함유하는 항생균제
ES2083401T3 (es) Procedimiento para la preparacion de penemas.
KR950025036A (ko) 퀴놀론 카르복실산 또는 이의 약제학적으로 허용되는 염의 제조방법
KR960704875A (ko) 방향족 아민을 n-시클로프로필화하는 새로운 방법과 그 화합물 및 조성물
KR890002019A (ko) 8-위치 치환된 퀴놀린 카복실산 유도체 및 그의 제조방법
KR890012995A (ko) 퀴놀론 유도체의 제조방법
FI851090L (fi) Foerfarande foer framstaellning av kinolinkarboxylsyraderivat.

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right